×

ANN LAB MED 2019 10.3343/alm.2019.39.6.545
Molecular Genetics of von Willebrand Disease in Korean Patients: Novel Variants and Limited Diagnostic Utility of Multiplex Ligation-Dependent Probe Amplification Analyses
Kim1, HJ; Kim, SK; Yoo, KY; Lee, KO; Yun, JW; Kim, SH; Kim, HJ; Park, SK

GENE CHROMOSOME CANC 2019 10.1002/gcc.22825
Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement
Yoon1, J; Yun, JW; Jung, CW; Ju, HY; Koo, HH; Kim, SH; Kim, HJ

J CLIN LAB ANAL 2019 10.1002/jcla.23064
Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia
Yun1, JW; Yoon, J; Jung, CW; Lee, KO; Kim, JW; Kim, SH; Kim, HJ

ANN LAB MED 2019 10.3343/alm.2019.39.6.515
Korean Society for Genetic Diagnostics Guidelines for Validation of Next Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies
Kim1, H; Yun, JW; Lee, ST; Kim, HJ; Kim, SH; Kim, JW

J CLIN LAB ANAL 2019 10.1002/jcla.22951
Clonal dominance of a donor-derived del(20q) clone after allogeneic hematopoietic stem cell transplantation in an acute myeloid leukemia patient with del(20q)
Yoon1, J; Yun, JW; Jung, CW; Kim, HJ; Kim, SH

ANN LAB MED 2019 10.3343/alm.2019.39.5.430
Flow Cytometric Analysis of T Cells in Hemophagocytic Lymphohistiocytosis
Park1, MS; Yoo, IY; Kim, HJ; Kim, SH; Kim, SJ; Cho, D

LEUKEMIA 2019 10.1038/s41375-018-0321-8
HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia
Park1, JH; Woo, YM; Youm, EM; Hamad, N; Won, HH; Naka, K; Park, EJ; Park, JH; Kim, HJ; Kim, SH; Kim, HJ; Ahn, JS; Sohn, SK; Moon, JH; Jung, CW; Park, S; Lipton, JH; Kimura, S; Kim, JW; Kim, D

HAEMATOL-HEMATOL J 2019 10.3324/haematol.2019.218487
Hereditary platelet function disorder from RASGRP2 gene mutations encoding CalDAG-GEFI identified by whole-exome sequencing in a Korean woman with severe bleeding
Yun1, JW; Lee, KO; Jung, CW; Oh, SY; Kim, SH; Choi, CW; Kim, HJ

INT J MOL SCI 2019 10.3390/ijms20071717
Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion
Yun1, JW; Bae, YK; Cho, SY; Koo, H; Kim, HJ; Nam, DH; Kim, SH; Chun, S; Joo, KM; Park, WY

ANN LAB MED 2019 10.3343/alm.2019.39.1.96
First Case of Plasma Cell Myeloma With Brown Tumor Features Unrelated to Hyperparathyroidism
Kim1, H; Kim, K; Cho, SR; Kim, HJ; Kim, SH

ANN LAB MED 2018 10.3343/alm.2018.38.6.495
Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia
Kim1, HY; Lee, KO; Park, S; Jang, JH; Jung, CW; Kim, SH; Kim, HJ

ANN HEMATOL 2018 10.1007/s00277-018-3358-x
Ethnicity-specific impact of HLA I/II genotypes on the risk of inhibitor development: data from Korean patients with severe hemophilia A
Kim1, HY; Cho, JH; Kim, HJ; Chung, HS; Kim, SH; Lee, KO; Jung, SY; Yoo, KY; Kim, HJ

EUR J HAEMATOL 2018 10.1111/ejh.13076
A novel type of+2-base pair frameshift CALR mutation in a patient with myeloproliferative neoplasm
Kim1, HY; Kim, JW; Kim, SH; Chang, MH; Kim, HJ

ANN LAB MED 2018 10.3343/alm.2018.38.3.196
Clinical Utility of a Diagnostic Approach to Detect Genetic Abnormalities in Multiple Myeloma: A Single Institution Experience
Jung1, HA; Jang, MA; Kim, K; Kim, SH

HEMATOL ONCOL 2017 10.1002/hon.2283
Macrophage inflammatory protein 1 alpha (MIP-1) may be associated with poor outcome in patients with extranodal NK/T-cell lymphoma
Kim1, HS; Ryu, KJ; Ko, YH; Kim, HJ; Kim, SH; Kim, WS; Kim, SJ

KOREAN JOURNAL OF INTERNAL MEDICINE 2017 10.3904/kjim.2015.406
Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea
Kim1, HS; Kim, HJ; Kim, SH; Choi, JY; Ko, YH; Kim, WS; Jung, CW; Kim, SJ

Hum Immunol. 2017 Feb;78(2):103-112. doi: 10.1016/j.humimm.2016.11.006. Epub 2016 Nov 21.
Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity
Phan MT11, Chun S2, Kim SH2, Ali AK3, Lee SH3, Kim S4, Kim SH5, Cho D6.

Ann Lab Med. 2017 Jan;37(1):66-70. doi: 10.3343/alm.2017.37.1.66.
Using Array-Based Comparative Genomic Hybridization to Diagnose Pallister-Killian Syndrome
Lee MN11, Lee J2, Yu HJ2, Lee J2, Kim SH3.

J Clin Lab Anal. 2016 Nov;30(6):1061-1070. doi: 10.1002/jcla.21981. Epub 2016 May 2.
Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean Patients
Yoo EH11, Park KJ2,3, Won HH2,3, Park JH2,3, Park JH2,3, Lee ST4, Kim HJ4, Bang SM5, Chi HS6, Jung CW7, Kim SH4, Yun H8, Sun CH8, Park I8, Lee S8, Lee C9, Merriman B9, Luo R10, Tan EH10, Park KJ11, Yoo NK11, Kang JJ9, Kim JW12.

J Clin Pathol. 2016 Aug;69(8):737-41. doi: 10.1136/jclinpath-2016-203649. Epub 2016 May 19.
High frequency of JAK2 exon 12 mutations in Korean patients with polycythaemia vera: novel mutations and clinical significance
Park CH11, Lee KO2, Jang JH3, Jung CW3, Kim JW1, Kim SH1, Kim HJ1.